GNC: FDA action on DMAA is ‘factually and legally unfounded’ Post a commentBy Elaine Watson, 27-Apr-2012
Related topics: Regulation, Energy & endurance
There is “no basis” for the Food and Drug Administration’s (FDA’s) decision to crack down on firms making supplements containing the stimulant DMAA (1,3-Dimethylamylamine), says retail giant GNC.
GNC spokesman Greg Miller was speaking to NutraIngredients-USA after the FDA sent warning letters to 10 manufacturers and distributors of supplements containing DMAA informing them that failure to immediately cease distribution of these products could result in enforcement action “without further notice”.
According to the FDA, synthetically produced DMAA is "not a dietary ingredient and is not, therefore, eligible to be used as an active ingredient in dietary supplements".
The agency also raised serious safety concerns about the stimulant, which it claimed caused increases in blood pressure which could in turn "increase the work of the heart such that it could precipitate a cardiovascular event".